Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2015, Article ID 716315, 13 pages
http://dx.doi.org/10.1155/2015/716315
Research Article

EPSTI1 Is Involved in IL-28A-Mediated Inhibition of HCV Infection

1Department of Molecular Medicine of College of Biology, State Key Laboratory of Chemo/Biosensing and Chemometrics, Hunan University, Changsha 410082, China
2Research Center of Cancer Prevention & Treatment, Translational Medicine Research Center of Liver Cancer, Hunan Provincial Tumor Hospital, Affiliated Tumor Hospital of Xiangya Medical School of Central South University, Changsha 410013, China

Received 13 March 2015; Accepted 17 May 2015

Academic Editor: Wenyu Lin

Copyright © 2015 Xianghe Meng et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [4 citations]

The following is the list of published articles that have cited the current article.

  • Martin Selinger, Gavin S. Wilkie, Lily Tong, Quan Gu, Esther Schnettler, Libor Grubhoffer, and Alain Kohl, “Analysis of tick-borne encephalitis virus-induced host responses in human cells of neuronal origin and interferon-mediated protection,” Journal of General Virology, 2017. View at Publisher · View at Google Scholar
  • Qingdong Guan, Peyman Ezzati, Victor Spicer, Oleg Krokhin, Donna Wall, and John A. Wilkins, “Interferon γ induced compositional changes in human bone marrow derived mesenchymal stem/stromal cells,” Clinical Proteomics, vol. 14, no. 1, 2017. View at Publisher · View at Google Scholar
  • Xiaosai Niu, Yuyang Wang, Min Li, Xiaorong Zhang, and Yantao Wu, “Transcriptome analysis of avian reovirus-mediated changes in gene expression of normal chicken fibroblast DF-1 cells,” BMC Genomics, vol. 18, no. 1, 2017. View at Publisher · View at Google Scholar
  • Wei-Chieh Huang, Shiao-Lin Tung, Yao-Li Chen, Po-Ming Chen, and Pei-Yi Chu, “IFI44L is a novel tumor suppressor in human hepatocellular carcinoma affecting cancer stemness, metastasis, and drug resistance via regulating met/Src signaling pathway,” BMC Cancer, vol. 18, no. 1, 2018. View at Publisher · View at Google Scholar